severe side effects semaglutide Ozempic is under fire with over 2676 lawsuits due to since August 2023. Novo Nordisk's injections Ozempic and Wegovy have faced lawsuits due to serious side effects. The cases Scientists' warning over 'severe' weight-loss

Rybelsus is FDA approved for two indications: glycemic control in adults with Type 2 diabetes, and cardiovascular risk reduction in adults with Type 2 diabetes who are at high cardiovascular risk (the latter approval came in October 2025)

native IGF-1's minute-scale half-life that requires constant infusion

Sandoz Group AG, Viatris Inc., Hikma Pharmaceuticals, Fresenius Kabi, Celltrion Inc., Samsung Bioepis, Dr

Dose Flexibility Compounding pharmacies can prepare semaglutide at a range of concentrations and doses, which gives providers more flexibility in tailoring the dose escalation to an individual patients tolerance and response